VWA
LFCR icon

Visionary Wealth Advisors’s Lifecore Biomedical LFCR Stock Holding History

Visionary Wealth Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-491,013
Closed -$2.52M – 545
2024
Q2 		$2.52M Sell
491,013
-5,766
-1% -$34.1K 0.16% 142
2024
Q1 		$2.64M Sell
496,779
-425
-0.1% -$3.04K 0.18% 140
2023
Q4 		$3.08M Sell
497,204
-4,130
-0.8% -$28.7K 0.23% 115
2023
Q3 		$3.78M Buy
501,334
+2,025
+0.4% +$18.5K 0.31% 89
2023
Q2 		$4.83M Sell
499,309
-960
-0.2% -$5.86K 0.39% 72
2023
Q1 		$1.89M Sell
500,269
-1,450
-0.3% -$8.08K 0.16% 133
2022
Q4 		$3.25M Sell
501,719
-22,770
-4% -$188K 0.3% 89
2022
Q3 		$4.66M Buy
524,489
+6,428
+1% +$65.4K 0.48% 56
2022
Q2 		$5.17M Sell
518,061
-475
-0.1% -$4.7K 0.46% 59
2022
Q1 		$6M Buy
518,536
+19,866
+4% +$221K 0.48% 51
2021
Q4 		$5.54M Sell
498,670
-8,905
-2% -$86.4K 0.45% 55
2021
Q3 		$4.68M Buy
507,575
+13,150
+3% +$143K 0.48% 52
2021
Q2 		$5.56M Buy
494,425
+17,550
+4% +$202K 0.56% 41
2021
Q1 		$5.05M Buy
476,875
+34,375
+8% +$386K 0.53% 48
2020
Q4 		$4.8M Buy
442,500
+40,173
+10% +$415K 0.54% 49
2020
Q3 		$3.91M Buy
402,327
+38,970
+11% +$371K 0.55% 50
2020
Q2 		$2.89M Buy
363,357
+4,750
+1% +$49K 0.44% 63
2020
Q1 		$3.12M Buy
358,607
+450
+0.1% +$4.68K 0.59% 55
2019
Q4 		$4.05M Buy
+358,157
New +$3.81M 0.73% 43

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Visionary Wealth Advisors's LFCR Position: Q3 2024 in Review

Visionary Wealth Advisors sold out of Lifecore Biomedical (LFCR) in Q3 2024, closing a stake of 491,013 shares — an estimated $2.52M sold.

Visionary Wealth Advisors first reported a position in LFCR in Q4 2019 and held it in 19 quarters. The position peaked at $6M in Q1 2022. 82 funds tracked by Wall St. Rank hold LFCR as of Q3 2024.

  • Visionary Wealth Advisors reported no remaining Lifecore Biomedical position as of Q3 2024 after selling out during the quarter.
  • Visionary Wealth Advisors sold 491,013 Lifecore Biomedical shares in Q3 2024, an estimated $2.52M.
  • Visionary Wealth Advisors first reported a position in Lifecore Biomedical in Q4 2019 and held it in 19 quarters.
  • Visionary Wealth Advisors's Lifecore Biomedical position peaked at $6M in Q1 2022.
  • 82 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2024.

Based on Visionary Wealth Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.